tiprankstipranks
Trending News
More News >
Zhongzhi Pharmaceutical Holdings Limited (HK:3737)
:3737
Hong Kong Market

Zhongzhi Pharmaceutical Holdings Limited (3737) Financial Statements

Compare
0 Followers

Zhongzhi Pharmaceutical Holdings Limited Financial Overview

Zhongzhi Pharmaceutical Holdings Limited's market cap is currently HK$703.01M. The company's EPS TTM is HK$0.121; its P/E ratio is 6.80; and it has a dividend yield of 47.29%. Zhongzhi Pharmaceutical Holdings Limited is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 2.21B¥ 2.05B¥ 1.83B¥ 1.75B¥ 1.60B
Gross Profit¥ 1.29B¥ 1.22B¥ 1.07B¥ 1.06B¥ 991.09M
Operating Income¥ 136.91M¥ 198.88M¥ 103.51M¥ 79.58M¥ 141.12M
EBITDA¥ 170.39M¥ 317.53M¥ 153.87M¥ 119.71M¥ 203.69M
Net Income¥ 95.21M¥ 162.78M¥ 106.39M¥ 52.13M¥ 138.53M
Balance Sheet
Cash & Short-Term Investments¥ 167.10M¥ 192.30M¥ 395.70M¥ 257.85M¥ 311.04M
Total Assets¥ 1.99B¥ 1.79B¥ 1.88B¥ 1.52B¥ 1.42B
Total Debt¥ 188.60M¥ 225.06M¥ 170.86M¥ 175.74M¥ 187.90M
Net Debt¥ 21.50M¥ 60.69M¥ -210.15M¥ -57.64M¥ -106.13M
Total Liabilities¥ 865.58M¥ 739.30M¥ 869.31M¥ 622.94M¥ 598.76M
Stockholders' Equity¥ 1.12B¥ 1.05B¥ 1.00B¥ 898.74M¥ 820.18M
Cash Flow
Free Cash Flow¥ 39.62M¥ -69.93M¥ 196.17M¥ -7.47M¥ -20.81M
Operating Cash Flow¥ 181.48M¥ 101.50M¥ 284.57M¥ 178.38M¥ 93.18M
Investing Cash Flow¥ -120.06M¥ -202.76M¥ 13.38M¥ -135.98M¥ -250.42M
Financing Cash Flow¥ 0.00¥ -154.62M¥ -68.14M¥ -40.83M¥ -71.93M
Currency in CNY

Zhongzhi Pharmaceutical Holdings Limited Earnings and Revenue History

Zhongzhi Pharmaceutical Holdings Limited Debt to Assets

Zhongzhi Pharmaceutical Holdings Limited Cash Flow

Zhongzhi Pharmaceutical Holdings Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis